Blue Abundance Biochemical: Net loss of 44.7789 million yuan in the first half of 2025, a year-on-year decrease of 67.87%.

Blue Peak Biochemistry announced that in the first half of 2025, the operating income was 1.196 billion yuan, an increase of 40.89% year-on-year. The net loss attributable to shareholders of the listed company was 44.7789 million yuan, a decrease of 67.87% compared to a loss of 139 million yuan in the same period last year. The company plans not to distribute cash dividends, bonus shares, or increase capital through capital reserves.